A method of administering liposomal encapsulated taxane

Details A method of administering liposomal encapsulated taxane A method of administering liposomal encapsulated taxane

A - Human Necessities

61

K

A61K 9/127 (2006.01) A61K 31/337 (2006.01) A61K 47/24 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2301057

Liposomal-encapsulated taxane or an antineoplastic derivative thereof or a mixture thereof is provided which is used to effect a therapeutically enhanced method of treating cancer. The liposomal encapsulated paclitaxel allows for administration to a patient, particularly a human patient, in less than one hour without substantial toxicity.

L'invention concerne un taxane liposomal encapsulé, un dérivé antinéoplastique de celui-ci ou un mélange de ceux-ci, utilisé pour obtenir un procédé thérapeutiquement amélioré de traitement du cancer. Le paclitaxel liposomal encapsulé peut être administré à un patient, en particulier un patient humain, en moins d'une heure sans toxicité importante.

Affiliated with

Also associated with

Rating

A method of administering liposomal encapsulated taxane does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with A method of administering liposomal encapsulated taxane, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A method of administering liposomal encapsulated taxane will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1790356